Navigation Links
Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
Date:10/29/2012

BOULDER, Colo., Oct. 29, 2012 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the first quarter of its fiscal year ending June 30, 2013.

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

Array continues its evolution into a late-stage development company, with five products approaching Phase 3 decisions by the end of calendar year 2013. These include two wholly-owned programs: ARRY-614 and ARRY-520, and three partnered programs: selumetinib (with AstraZeneca), MEK162 (with Novartis) and danoprevir (with InterMune/Roche). 

Array reported revenue of $15.8 million for the first quarter of fiscal 2013, compared to revenue of $22.1 million for the same period in fiscal 2012.  The decrease in first quarter revenue was expected, as Array recognized the majority of its $28 million upfront payment from a license agreement with Genentech during the previous fiscal year. The Company recorded expenses of $13.5 million on proprietary research and development for the quarter to advance its clinical development and discovery programs, compared to $12.6 million during the same period last year.  Net loss for the first quarter was $11.8 million, or ($0.13) per share, compared to $3.6 million, or ($0.06) per share, for the same period last year. Array ended the first quarter of fiscal 2013 with $68 million in cash, cash equivalents, and marketable securities.Ron Squarer, Chief Executive Officer of Array, noted, "This promises to be an important year for Array as several drugs in our wholly-owned and partnered pipelines move towards commercialization. We are on track to advance ARRY-520 for multiple myeloma and ARRY-614 for myelodysplastic syndromes into late-stage development in the coming year.  Success with any of these programs will propel
'/>"/>

SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
2. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
3. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
4. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
5. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
6. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
7. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
8. S1 Biopharma Expands Focus to Include Male Sexual Health
9. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
10. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
11. Cell Therapeutics Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Conn. , June 18, 2013  It ... clients of Alliance Seating and Mobility, a subsidiary ... to access timely repair. This appears to be ... dramatic reduction of field service employees.  ... a great many of these clients are complex ...
(Date:6/18/2013)... LEANDRO, Calif. , June 18, 2013  Cataracts ...  According to the American Association of Ophthalmology, aging is ... a clouding of the eye,s natural lens. 22 million ... 2020, as Baby Boomers continue to age, that number ... high tech world of iPhones, iPads, smart-phones and computers, ...
(Date:6/18/2013)... Mass. , June 18, 2013  Decision ... advisory firms for pharmaceutical and healthcare issues, announces ... coverage of the Middle East ... Access Tracker analyzes the challenges and opportunities to ... four international regions comprising 24 countries. The countries ...
Breaking Medicine Technology:New Vision Hope For Millions Undergoing Cataract Surgery 2New Vision Hope For Millions Undergoing Cataract Surgery 3Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 2Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 3
... , SEOUL, South Korea, Nov. 17 ... Securities Dealers Association Quotation System ("Arigene") (KOSDAQ: 067850), today announced ... announced merger agreement dated October 2, 2009 with Trimeris, Inc. ... of the expiration date of the tender offer being conducted ...
... , MARCY L,ETOILE, France, Nov. 17 bioMerieux ... test to help clinicians select the most appropriate treatment for ... emerging biomarkers, will be intended for use in both adjuvant ... 500,000 new cases of breast cancer are diagnosed each year ...
Cached Medicine Technology:Arigene Co., Ltd. Enters Into Amendment To Merger Agreement With Trimeris, Inc. 2Arigene Co., Ltd. Enters Into Amendment To Merger Agreement With Trimeris, Inc. 3Arigene Co., Ltd. Enters Into Amendment To Merger Agreement With Trimeris, Inc. 4bioMerieux and GSK Sign Theranostics Agreement to Develop Predictive Test for Selecting Breast Cancer Treatment 2bioMerieux and GSK Sign Theranostics Agreement to Develop Predictive Test for Selecting Breast Cancer Treatment 3
(Date:6/19/2013)... 2013 Indosoft Inc., developers of ... for Asterisk, announced today the availability of its ... offers improved options for extracting, consolidating and presenting ... contact center management. , Large Asterisk based contact ... it happens from the call center software. This ...
(Date:6/19/2013)... CoachingWebsites, the leading ... today its affiliation with Active Intelligence. ... websites and marketing solutions and capitalize on affiliate ... with Active Intelligence shows our overall dedication to ... says Greer Van Dyck, Online Marketing Expert at ...
(Date:6/19/2013)... 19, 2013 The Mesothelioma Victims ... Control of the 2500 to 3000 citizens, who will ... mesothelioma this year, about one third will be US ... diagnosed with this asbestos exposure form of cancer, or ... access to the nations most skilled mesothelioma compensation settlement ...
(Date:6/19/2013)... Francisco, CA (PRWEB) June 19, 2013 ... accelerating throughout 2013 across all industries as cash rich ... Despite the differences across industries, all M&A transactions have ... rigorous due diligence to verify the history and quality ... carefully considered. , But when due diligence involves ...
(Date:6/18/2013)... oBand Surgery Centers, a reputed name ... weight loss seminars in Los Angeles this month. Scheduled ... at their official website. oBand Surgery Centers are an ... highly skilled panel of surgeons and dedicated staff has ... senior executive working with oBand Surgery Centers said, “We ...
Breaking Medicine News(10 mins):Health News:Indosoft Improves Q-Suite Real-time ACD Reporting to Enhance Contact Center Productivity 2Health News:CoachingWebsites (Websites for Coaches) Announces Their Partnership With Active Intelligence, LLC 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 3Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 2Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 3Health News:oBand Surgery Centers Will Hold Complimentary Weight Loss Seminars in Los Angeles in June 2
... lowering LDL cholesterol (“bad” cholesterol) to below 100 milligrams ... cholesterol-lowering drug is safe and results in fewer cardiovascular ... They initially took 10 milligrams of atorvastatin (Lipitor) a ... milligrams per deciliter a day or lower. Then, half ...
... A study conducted in Spain has focused on the ... which might be associated with an increased risk of ... during pregnancy has been proven to have disastrous effects ... period, and obstetric complications such as extra uterine pregnancy, ...
... gradually increased recommendations for daily calcium intake, largely from ... to promote healthy bones and prevent osteoporosis. But a ... of milk or other dairy products was not necessarily ... of at least 400 milligrams per day. ,Other ...
... also hide within the body for long periods of time, ... resistance is lowered. The latent infections thus pose repeated problems ... study researchers say a compound found in licorice is showing ... virus that lingers in the body. For the study researchers ...
... suffering from the bone-thinning disease osteoporosis may also be ... condition in which people have a difficult time digesting ... improve bone mineral density, or BMD, among patients with ... have thinning bones, but little study exists to suggest ...
... new way to boost stem cell research that will help ... a new way of growing human embryonic stem cells in ... potential to play an important role in regeneration of cells ... these are exposed to live animal cells and serum and ...
Cached Medicine News:
PDA application containing all 7,000+ Physicians' Current Procedural Terminology codes developed by the American Medical Association....
More than 200 key diagnostic and treatment tables culled from Tierney's Current Medical Diagnostics and Treatment 2003....
Consists of the print and PDA versions of Harrison's Manual of Medicine 15th Edition. Provides high-end medical content via PDA....
... BD Safety Knife with BD Xstar Blade ... that protects the blade in prodedure and ... based on a grind-less process for manufacturing ... outstanding sharpness and consistency. The arch ...
Medicine Products: